GeneDx announced on March 13, 2025, the introduction of Multiscore, an advanced AI-powered decision support tool integrated into its interpretation platform. Multiscore is designed to revolutionize genetic analysis by improving diagnostic efficiency, streamlining workflows, and enhancing clinical insights.
The tool prioritizes genes in exome and genome sequences by ranking them based on alignment with a patient’s clinical presentation, leveraging GeneDx’s proprietary dataset and publicly available data. This approach enables faster and more accurate identification of genetic conditions, even in complex cases where symptoms may not fit textbook descriptions.
Multiscore is expected to reduce the time required for manual review by clinical geneticists, ultimately shortening the overall turnaround time for delivering results. This innovation, which will be showcased at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting, reinforces GeneDx's leadership in applying AI to genomics and its commitment to scalable diagnostic solutions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.